Skip to main content

Kristin Stafford

Equibles does not estimate personal net worth.

Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.

Get NVCR alerts

About Kristin Stafford

Kristin Stafford is recorded as Board Member at NovoCure Ltd (NVCR) since June 3, 2026 and CFO and Chief Accounting Officer at NovoCure Ltd (NVCR). The newest filing on record that lists Kristin Stafford as CFO at NovoCure Ltd (NVCR) is dated April 20, 2026. The newest filing on record that lists Kristin Stafford as Chief Accounting Officer at NovoCure Ltd (NVCR) is dated April 21, 2025. NovoCure Ltd reported in an 8-K filed June 5, 2026 that Kristin Stafford was appointed director, effective June 3, 2026. NovoCure Ltd reported in an 8-K filed June 6, 2025 that Kristin Stafford was appointed director, effective June 4, 2025. NovoCure Ltd reported in an 8-K filed June 10, 2024 that Kristin Stafford was appointed director, effective June 5, 2024. Equibles holds 5 filed executive changes naming Kristin Stafford; each is listed under recent activity with its source filing. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.

“The Company’s shareholders elected Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Frank Leonard, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2027.”
NovoCure Ltd Form 8-K, filed June 5, 2026 · Read the filing
“The Company's shareholders elected Ashley Cordova, Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2026.”
NovoCure Ltd Form 8-K, filed June 6, 2025 · Read the filing

Affiliation history

Company network

Current role

Medical Devices · Healthcare

CFO, Chief Accounting Officer, Board Member

2026-06-03–present

Leadership on record at NovoCure Ltd

Recent activity